ON
Om Narayana Rao Mulleti
About Om Narayana Rao Mulleti
Data last updated:
Om Narayana Rao Mulleti was a Director at Bharath Healthcare Laboratories Private Limited (2017–2023), Additional Director at Digital Education Ecosystem India Private Limited (2017–2018) and Additional Director at Dzpay Private Limited (2017–2018), and held 2 more directorships. The companies operate in Healthcare, Business Services and Financial Services.
Previous companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 25 Oct 2017 | 2016 | ₹34.67 Cr (FY 2024) | Active | |
| Additional Director | 25 Oct 2017 | 2017 | Active | ||
| Additional Director | 25 Oct 2017 | 2017 | ₹18.3 Lakh (FY 2025) | Active | |
| Additional Director | 25 Oct 2017 | 2017 | ₹1.4 Lakh (FY 2023) | Active | |
| Additional Director | 25 Oct 2017 | 2006 | ₹98.4 Lakh (FY 2022) | Active |
Explore Director's current and past company associations Uncover their professional journey today!
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Om Narayana Rao Mulleti
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Om Narayana Rao Mulleti
Om Narayana Rao Mulleti was first appointed on 25 Oct 2017 as Director at Bharath Healthcare Laboratories Private Limited.
Om Narayana Rao Mulleti held 5 earlier board appointments: Bharath Healthcare Laboratories Private Limited (Director, 25 Oct 2017 to 15 Apr 2023); Digital Education Ecosystem India Private Limited (Additional Director, 25 Oct 2017 to 12 Apr 2018); Dzpay Private Limited (Additional Director, 25 Oct 2017 to 12 Apr 2018); India-Herald Publishers Private Limited (Additional Director, 25 Oct 2017 to 12 Apr 2018); Bharath Innovation Labs Private Limited (Additional Director, 25 Oct 2017 to 11 Sep 2019).